BioSpace News Archive

Genetown

Moderna’s Omicron-Containing Bivalent Booster Candidate, mRNA-1273.214, Demonstrates Significantly Higher Neutralizing Antibody Response Against Omicron Subvariants BA.4/5 Compared To Currently Authorized Booster

Moderna today announced new clinical data on its bivalent Omicron (BA.1) booster candidate, mRNA-1273.214.

July 11, 2022
·
7 min read
Business

Enavate Sciences Appoints Industry Veteran Robert Glassman as Executive Vice President, Search & Evaluation

Enavate Sciences , a platform launched by Patient Square Capital to support transformative therapeutic companies, announced today the appointment of Robert Glassman, M.D., as Executive Vice President, Search & Evaluation.

July 11, 2022
·
3 min read
Biotech Beach

Sientra Wins Premier’s Horizon Award for 2022 for Exceptional Customer Service, Engagement, and Value Creation

Sientra, Inc., a leading medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, was recently honored with the 2022 Supplier Horizon Award.

July 11, 2022
·
5 min read
Brand Institute Partners on Brand Name Development for FDA Approved Treatment for Attention Deficit Hyperactivity Disorder (ADHD)

Brand Institute is proud to announce its work with Osmotica Pharmaceuticals in developing the brand name RELEXXII®.

July 11, 2022
·
2 min read
Business

SafeHeal Appoints Medical Device Industry Veteran Chris Richardson as Chief Executive Officer

SafeHeal, a leading innovator in the field of digestive surgery and developer of the Colovac device, announced the appointment of Chris Richardson as Chief Executive Officer, who assumes responsibilities immediately.

July 11, 2022
·
3 min read
Bio NC

Seqirus Begins Shipping Portfolio of Innovative Influenza Vaccines for the 2022/23 U.S. Season

Seqirus, a global leader in influenza prevention and a business of CSL Limited, announced that it has begun to ship its portfolio of innovative cell-based, adjuvanted and egg-based seasonal influenza vaccines across the U.S. in preparation for the 2022/23 influenza season.

July 11, 2022
·
14 min read
Pharm Country

GSK prepares US for 2022-23 flu season with over 50 million influenza vaccine doses

GSK plc announced it has started shipping doses of its quadrivalent influenza vaccines to US healthcare providers and pharmacies in preparation for the 2022-23 season.

July 11, 2022
·
6 min read